ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $72,713,000 | +183.2% | 1,569,465 | +49.0% | 0.02% | +166.7% |
| Q1 2019 | $25,674,000 | +198.3% | 1,053,075 | +105.3% | 0.01% | +200.0% |
| Q2 2018 | $8,607,000 | +27.1% | 512,917 | +23.6% | 0.00% | 0.0% |
| Q1 2018 | $6,774,000 | -8.3% | 415,022 | -30.9% | 0.00% | 0.0% |
| Q3 2017 | $7,389,000 | +109.9% | 600,721 | +42.8% | 0.00% | +100.0% |
| Q2 2017 | $3,520,000 | +37.8% | 420,589 | +47.2% | 0.00% | 0.0% |
| Q1 2017 | $2,554,000 | +1.9% | 285,638 | -48.0% | 0.00% | 0.0% |
| Q3 2015 | $2,507,000 | +144.1% | 549,798 | +286.1% | 0.00% | – |
| Q2 2015 | $1,027,000 | +89.1% | 142,412 | +19.5% | 0.00% | – |
| Q2 2014 | $543,000 | -3.0% | 119,181 | 0.0% | 0.00% | – |
| Q1 2014 | $560,000 | -17.0% | 119,181 | -11.5% | 0.00% | – |
| Q4 2013 | $675,000 | -21.4% | 134,681 | -2.5% | 0.00% | – |
| Q3 2013 | $859,000 | -30.4% | 138,081 | -49.2% | 0.00% | – |
| Q2 2013 | $1,234,000 | – | 271,881 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
| APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
| BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
| First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
| SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
| GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
| Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
| X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |